Variant report
Variant | esv1006039 |
---|---|
Chromosome Location | chr8:104745611-104750214 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:104743578..104746366-chr8:104850562..104852929,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147035323 | chr8:104745669-104745670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148074275 | chr8:104745701-104745702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77529223 | chr8:104745718-104745719 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
4 | rs141844441 | chr8:104745740-104745741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559102013 | chr8:104745776-104745777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113760168 | chr8:104745787-104745788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566016215 | chr8:104745809-104745810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs75931837 | chr8:104745854-104745855 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
9 | rs557717173 | chr8:104745915-104745916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs193239147 | chr8:104745917-104745918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576177855 | chr8:104745939-104745940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536806269 | chr8:104745947-104745948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555444789 | chr8:104745962-104745963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150209848 | chr8:104746031-104746032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562404127 | chr8:104746036-104746037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375639806 | chr8:104746079-104746080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558899743 | chr8:104746085-104746086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185722523 | chr8:104746100-104746101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577964122 | chr8:104746121-104746122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545673492 | chr8:104746203-104746204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138836574 | chr8:104746226-104746227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59348302 | chr8:104746267-104746268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76493959 | chr8:104746270-104746271 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
24 | rs77198979 | chr8:104746272-104746273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531134863 | chr8:104746282-104746283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190222689 | chr8:104746327-104746328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs28697136 | chr8:104746351-104746352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs564527356 | chr8:104746389-104746390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181729586 | chr8:104746390-104746391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185541408 | chr8:104746460-104746461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112990563 | chr8:104746484-104746485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553747360 | chr8:104746518-104746519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369609049 | chr8:104746546-104746547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7459857 | chr8:104746563-104746564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1184408 | chr8:104746571-104746572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1426289 | chr8:104746578-104746579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375630439 | chr8:104746616-104746617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4333556 | chr8:104746639-104746640 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs4541867 | chr8:104746645-104746646 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs200420002 | chr8:104746688-104746689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148688078 | chr8:104746701-104746702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537274551 | chr8:104746703-104746704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376025455 | chr8:104746713-104746714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539989556 | chr8:104746720-104746721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534408679 | chr8:104746766-104746767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552591039 | chr8:104746773-104746774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146012095 | chr8:104746780-104746781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76990114 | chr8:104746795-104746796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139971018 | chr8:104746797-104746798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575812068 | chr8:104746930-104746931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 20409316 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Prostate cancer | 22341455 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:104743600-104749600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:104744000-104752000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr8:104746400-104747800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:104747000-104747200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr8:104747200-104753800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr8:104747800-104748000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr8:104749600-104750000 | Enhancers | NHEK | skin |
8 | chr8:104749600-104750200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr8:104749600-104750200 | Enhancers | HUVEC | blood vessel |
10 | chr8:104749600-104750400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr8:104749800-104750200 | Enhancers | HMEC | breast |
12 | chr8:104750200-104751800 | Weak transcription | HUVEC | blood vessel |